Billionaire Profile
Stéphane Bancel
Global Rank
#1988

Image: Brenda Bancel | GFDL | via Wikimedia Commons

Stéphane Bancel

CEO, Biotech
FRANCE
Real-Time Net Worth
$2.042B
Estimated based on Biotech stock value as of March 6, 2026
-5.53% (24h)
Age
53
Source
Biotech, vaccines
Industry
Healthcare
Citizenship
FRANCE

Biography

Stéphane Bancel is a French billionaire businessman and the CEO of Moderna, a biotechnology company specializing in messenger RNA (mRNA) medicines. Born in Marseille, France, on July 20, 1972, Bancel holds degrees from CentraleSupélec, the University of Minnesota, and Harvard Business School. His career includes roles at Eli Lilly and Company and as CEO of bioMérieux before joining Moderna in 2011. Bancel's net worth is estimated at $1.7 billion as of early 2024. His source of wealth is primarily from his stake in Moderna, particularly its success with the COVID-19 vaccine. Bancel is known for his leadership in mRNA technology and his commitment to philanthropy, planning to donate a significant portion of his wealth.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Stéphane Bancel was born in Marseille, France, on July 20, 1972. His parents were an engineer and a doctor. During his childhood, Bancel enjoyed science and math. He studied engineering at CentraleSupélec and biological engineering at the University of Minnesota, earning master's degrees from both institutions. He then earned an MBA from Harvard Business School.

Rise to Success

Bancel's career began as a sales director at Eli Lilly and Company, later becoming the head of operations for Belgium. In 2007, he became the CEO of BioMérieux, where he improved the company's margins. In 2011, Bancel became the CEO of Moderna. Under his leadership, Moderna developed a highly successful COVID-19 vaccine, which significantly increased the company's profile and Bancel's net worth.

Key Business Strategies

Bancel has led Moderna through several key strategic moves, including raising $2 billion in venture capital funding between 2011 and 2017. He owns a significant stake in Moderna, approximately 5.5%. Bancel's leadership style is described as results-oriented and focused on strategic vision.

Philanthropy

Bancel has stated that he plans to donate most of his wealth to charity. His philanthropic interests include healthcare, education, global food security, and addressing inequality. He is committed to several foundations and has plans to sell a significant portion of his shares to fund his charitable endeavors.

Career Milestones

2007

CEO of bioMérieux

Bancel became the CEO of the French diagnostics company BioMérieux.

2011

CEO of Moderna

Bancel joined Moderna as CEO.

2021

Named Chevalier de la Légion d'honneur

Bancel was appointed as a knight in the French Legion of Honor.

Philanthropy & Social Impact

Healthcare, education, global food security, and inequality

Undisclosed Charitable Causes

$355M

Bancel plans to donate the proceeds from selling most of his Moderna shares.

Business Philosophy & Leadership

Notable Quotes

""You cannot make a return on investment if you don't have access to the U.S. market.”"